AU2003250338A1 - Medicament combinations of sodium channel blockers and fibrinolytics for treating ischaemic conditions - Google Patents

Medicament combinations of sodium channel blockers and fibrinolytics for treating ischaemic conditions

Info

Publication number
AU2003250338A1
AU2003250338A1 AU2003250338A AU2003250338A AU2003250338A1 AU 2003250338 A1 AU2003250338 A1 AU 2003250338A1 AU 2003250338 A AU2003250338 A AU 2003250338A AU 2003250338 A AU2003250338 A AU 2003250338A AU 2003250338 A1 AU2003250338 A1 AU 2003250338A1
Authority
AU
Australia
Prior art keywords
fibrinolytics
sodium channel
channel blockers
medicament combinations
ischaemic conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003250338A
Other languages
English (en)
Inventor
Sophie Banzet
Hermann Duettmann
Annerose Mauz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
BOEHRINGER INGELHEIM PHARMA
Boehringer Ingelheim Pharma GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BOEHRINGER INGELHEIM PHARMA, Boehringer Ingelheim Pharma GmbH and Co KG filed Critical BOEHRINGER INGELHEIM PHARMA
Publication of AU2003250338A1 publication Critical patent/AU2003250338A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003250338A 2002-06-15 2003-06-04 Medicament combinations of sodium channel blockers and fibrinolytics for treating ischaemic conditions Abandoned AU2003250338A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10226814.2 2002-06-15
DE10226814A DE10226814A1 (de) 2002-06-15 2002-06-15 Neue Arzneimittelkombinationen zur Behandlung ischämischer Zustände
PCT/EP2003/005813 WO2003105844A1 (de) 2002-06-15 2003-06-04 Arzneimittelkombinationen aus natriumkanalblockern und fibrinolytika zur behandlung ischämischer zustände

Publications (1)

Publication Number Publication Date
AU2003250338A1 true AU2003250338A1 (en) 2003-12-31

Family

ID=29719139

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003250338A Abandoned AU2003250338A1 (en) 2002-06-15 2003-06-04 Medicament combinations of sodium channel blockers and fibrinolytics for treating ischaemic conditions

Country Status (6)

Country Link
EP (1) EP1515720A1 (de)
JP (1) JP2005536478A (de)
AU (1) AU2003250338A1 (de)
CA (1) CA2485751A1 (de)
DE (1) DE10226814A1 (de)
WO (1) WO2003105844A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1941879A1 (de) * 2007-01-05 2008-07-09 PAION Deutschland GmbH Nervenschutzmittel zur Behandlung von neuronalen Schäden.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19740110A1 (de) * 1997-09-12 1999-03-18 Boehringer Ingelheim Pharma Substituierte 1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocin-10-ole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
ATE361089T1 (de) * 2001-02-02 2007-05-15 Ortho Mcneil Pharm Inc Behandlung von neurologischen funktionsstörungen mit fructopyranosesulfamaten und erythropoetin

Also Published As

Publication number Publication date
DE10226814A1 (de) 2004-01-08
EP1515720A1 (de) 2005-03-23
JP2005536478A (ja) 2005-12-02
CA2485751A1 (en) 2003-12-24
WO2003105844A1 (de) 2003-12-24

Similar Documents

Publication Publication Date Title
ZA201207323B (en) Method of treatment of prophylaxis
EP1689412A4 (de) Vitamin-d-analoga zur prävention und behandlung von adipositas
AU2003209851A1 (en) Method of treatment and/or prophylaxis
AU2002315814A1 (en) Medicinal composition for treatment of interstitial cystitis
AU2003903387A0 (en) Combination therapy for treatment of neoplasia
AU2003272728A1 (en) Methods and compositions for treatment of neurological disorder
AU2003237969A1 (en) Pharmaceutical composition comprising calcium channel blockers for the treatment of pain
AU2003291886A1 (en) Thiophenederivatives for the treatment of flavivirus infections
AU2002359177A1 (en) Use of interleukin-6 for treatment of obesity
AU2003250338A1 (en) Medicament combinations of sodium channel blockers and fibrinolytics for treating ischaemic conditions
HUP0300990D0 (en) Synergistic combination for the prophylaxis and treatment of diabetes
IL166062A0 (en) Compositions and methods for therapeutic treatment
IL165300A0 (en) Method of prophylaxis of infection
AU2003283938A1 (en) Use of certain compounds in treatment of obesity
GB0221712D0 (en) Methods of treatment
AU2002951913A0 (en) Method of treatment
AU2003284623A1 (en) Medicinal composition for treating sudden deafness
AU2003291461A8 (en) Compositions for diabetes treatment and prophylaxis
EP1660007A4 (de) Zusammensetzungen für die behandlung und prophylaxe von diabetes
AU2003229335A8 (en) Compositions and methods for treatment of wounds
AU2003224561A1 (en) Use of dhea for treatment of female hypopituitarism
AU2003907193A0 (en) A method of treatment and prophylaxis
AU2003209489A1 (en) Medical use of captopril for the treatment and prophylaxis of cancer
AU2003276123A1 (en) Treatment of uveal melanoma
AU2004907304A0 (en) A method of treatment and prophylaxis

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase